We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Thoracic Stent Graft Improves Aortic Aneurysm Repair

By HospiMedica staff writers
Posted on 18 Jun 2008
A thoracic stent graft system has been developed for minimally invasive treatment of aneurysms of the descending thoracic aorta. More...


The Talent Thoracic Stent Graft System is a modular, self-expanding prosthesis designed for endoluminal exclusion of aortic aneurysms. It consists of a series of serpentine nickel-titanium (nitinol) stents embedded into woven Dacron fabric; the stents are spaced discontinuously along a full-length nitinol spine. The delivery system is a coaxial sheath with pusher rod and a compliant polyurethane balloon used to maximize attachment to the vascular wall and ensure full expansion throughout the length of the device. The Talent is available in a wide range of diameters, from 22 to 46 mm. This offers physicians multiple options to customize devices for their patients' needs and to treat a wider range of anatomies than with the other available endografts, making thoracic endovascular aortic repair (TEVAR) accessible to an additional 25% of patients. Salient features of the Talent device include the proximal bare-spring (uncovered nitinol stent) and custom manufacturing to fit a wide range of aorto-iliac sizes and configurations, as determined preoperatively by computed-tomographic (CT) imaging and angiography. The Talent Thoracic Stent Graft System is a product of Medtronics (Minneapolis, MN, USA), and has been approved by the U.S. Food and Drug Administration (FDA).

"There are still many patients undiagnosed and in need of treatment for thoracic aortic disease,” said Ronald Fairman, M.D., a professor of surgery and chief of vascular surgery at the University of Pennsylvania Hospital (Philadelphia, USA). "FDA approval of the Talent Thoracic Stent Graft is an important development in physicians' abilities to treat this life-threatening condition. In my own experience, this device offers a superior alternative to open surgery and will allow physicians to perform minimally-invasive thoracic aortic aneurysm repair for a broader population of patients.”

Thoracic aneurysms most often occur in the descending thoracic aorta. Others may appear in the ascending aorta or the aortic arch. The most common cause of a thoracic aortic aneurysm is atherosclerosis. Other risk factors include various connective tissue disorders such as Marfan syndrome, previous dissection of the aorta, high blood pressure, trauma such as falls or motor vehicle accidents, and syphilis. For patients with aneurysms of the ascending aorta or aortic arch, surgery to replace the aorta is recommended if the aneurysm is larger than 5-6 cm. There are two options for patients with aneurysms of the descending thoracic aorta; if the aneurysm is larger than six cm, major surgery is done to replace the aorta with a fabric substitute. Endovascular stenting is a less invasive option.


Related Links:
Medtronics

New
Gold Member
Neonatal Heel Incision Device
Tenderfoot
Gold Member
12-Channel ECG
CM1200B
New
Desk Aneroid Sphyg
Diagnostix 750D+
New
Monitor/Defibrillator
Zenix
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Health IT

view channel
Photo courtesy of Adobe Stock

Automated System Classifies and Tracks Cardiogenic Shock Across Hospital Settings

Cardiogenic shock remains a difficult, time-sensitive emergency, with delayed identification driving poor outcomes and persistently high mortality. Many cases go undocumented even at advanced stages, hindering... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.